0.84USD
20.76 MUSD
21.55 MUSD
12.94 M
About Cipher Pharmaceuticals, Inc.
Sector
CEO
Craig Mull
Headquarters
Mississauga
Website
Founded
2000
ISIN
CA17253X1050
FIGI
BBG00FY0BW05
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Mississauga, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CPHRF is 6.35 USD — it has decreased by 0.88% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Cipher Pharmaceuticals, Inc. stocks are traded under the ticker CPHRF.
Cipher Pharmaceuticals, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
CPHRF stock is 1.91% volatile and has beta coefficient of −0.31. Check out the list of the most volatile stocks — is Cipher Pharmaceuticals, Inc. there?
One year price forecast for Cipher Pharmaceuticals, Inc. has a max estimate of 6.84 USD and a min estimate of 5.91 USD.
CPHRF earnings for the last quarter are 0.27 USD whereas the estimation was 0.07 USD which accounts for 285.71% surprise. Estimated earnings for the next quarter are 0.10 USD. See more details about Cipher Pharmaceuticals, Inc. earnings.
Cipher Pharmaceuticals, Inc. revenue for the last quarter amounts to 6.07 M USD despite the estimated figure of 5.25 M USD. In the next quarter revenue is expected to reach 5.23 M USD.
Yes, you can track Cipher Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
CPHRF stock has risen by 5.90% compared to the previous week, the month change is a 5.37% rise, over the last year Cipher Pharmaceuticals, Inc. has showed a 155.18% increase.
CPHRF net income for the last quarter is 7.87 M USD, while the quarter before that showed 6.94 M USD of net income which accounts for 13.32% change. Track more Cipher Pharmaceuticals, Inc. financial stats to get the full picture.
Today Cipher Pharmaceuticals, Inc. has the market capitalization of 153.83 M, it has increased by 0.03% over the last week.
No, CPHRF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CPHRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cipher Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cipher Pharmaceuticals, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cipher Pharmaceuticals, Inc. stock shows the buy signal. See more of Cipher Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Cipher Pharmaceuticals, Inc. future price: according to them, CPHRF price has a max estimate of 6.84 USD and a min estimate of 5.91 USD. Read a more detailed Cipher Pharmaceuticals, Inc. forecast: see what analysts think of Cipher Pharmaceuticals, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Cipher Pharmaceuticals, Inc. EBITDA is 11.46 M USD, and current EBITDA margin is 53.21%. See more stats in Cipher Pharmaceuticals, Inc. financial statements.